Related Experiment Video
Updated: Feb 9, 2026

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
Tumour-associated missense mutations in the dMi-2 ATPase alters nucleosome remodelling properties in a
Kristina Kovač1, Anja Sauer1, Igor Mačinković1
1Institute for Molecular Biology and Tumour Research, University of Marburg, 35043, Marburg, Germany.
Abstract:
ATP-dependent chromatin remodellers are mutated in more than 20% of human cancers. The consequences of these mutations on enzyme function are poorly understood. Here, we characterise the effects of CHD4 mutations identified in endometrial carcinoma on the remodelling properties of dMi-2, the highly conserved Drosophila homologue of CHD4. Mutations from different patients have surprisingly diverse defects on nucleosome binding, ATPase activity and nucleosome remodelling. Unexpectedly, we identify both mutations that decrease and increase the enzyme activity. Our results define the chromodomains and a novel regulatory region as essential for nucleosome remodelling. Genetic experiments in Drosophila demonstrate that expression of cancer-derived dMi-2 mutants misregulates differentiation of epithelial wing structures and produces phenotypes that correlate with their nucleosome remodelling properties. Our results help to define the defects of CHD4 in cancer at the mechanistic level and provide the basis for the development of molecular approaches aimed at restoring their activity.
Insights
Mutations in ATP-dependent chromatin remodellers, found in over 20% of cancers, have diverse effects on enzyme function. This study reveals how specific CHD4 mutations impact cancer by altering DNA remodelling properties.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- ATP-dependent chromatin remodellers are frequently mutated in human cancers.
- The functional consequences of these mutations on enzyme activity are not well understood.
Purpose of the Study:
- To characterize the effects of CHD4 mutations found in endometrial carcinoma on the remodelling properties of its Drosophila homologue, dMi-2.
- To elucidate the mechanistic defects of CHD4 in cancer and inform potential therapeutic strategies.
Main Methods:
- Biochemical assays to assess nucleosome binding, ATPase activity, and nucleosome remodelling of dMi-2 mutants.
- Genetic experiments in Drosophila to evaluate the in vivo consequences of cancer-derived dMi-2 mutations.
Main Results:
- CHD4 mutations exhibit diverse defects in nucleosome binding, ATPase activity, and remodelling, with some increasing enzyme activity.
- The chromodomains and a novel regulatory region are identified as crucial for nucleosome remodelling.
- Expression of cancer-derived dMi-2 mutants in Drosophila leads to misregulation of epithelial wing structure differentiation, correlating with remodelling properties.
Conclusions:
- Cancer-associated CHD4 mutations have varied impacts on enzyme function, affecting chromatin remodelling.
- Understanding these mechanistic defects provides a foundation for developing therapies to restore CHD4 activity in cancer.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Point and Frameshift Mutations

